AstroNova Reports Fiscal Fourth-Quarter and Full-Year 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Netflix earnings forecast disappoints Wall Street, shares tumble
- Alphabet stock falls on report of Gemini AI model delays
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil settles lower, but remains near one-month high on U.S.-Iran tension
- FDA approves Merck's Lipfendra as first oral PCSK9 inhibitor
- Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
- Boeing nears approval of 737 MAX anti-ice fix, paving way for deliveries
AstroNova (ALOT) Tops Q4 EPS by 11c
April 14, 2022 7:35 AM EDTAstroNova (NASDAQ: ALOT) reported Q4 EPS of $0.12, ex-items, $0.11 better than the analyst estimate of $0.01. Revenue for the quarter came in at $29.7 million versus the consensus estimate of $29.69 million.
Backlog as of January 31, 2022 was $27.8 million versus $22.5 million at the end of the fiscal 2021 fourth... More
